Individual weight loss results vary based on factors such as individual response to the medication, initial body weight, and lifestyle habits
Drug-Drug Interactions: Semaglu-2 (8mg/3ml) Pfp Injection 1's potentially interacts with certain medications used to treat certain cancers (e.g., bexarotene, capivasertib), certain general anaesthetics (e.g., desflurane, enflurane, etomidate, fospropofol, halothane, isoflurane, ketamine), antibiotics (e.g., gatifloxacin), certain insulin or sulfonylureas (e.g., glimepiride, glyburide) and certain GLP1 receptor agonists or similar weight-loss medications (e.g., liraglutide, tirzepatide)
Sex differences in the recognition, monitoring, and management of CKD in health care: an observational cohort study
FDA review decision expected approximately October 2026
Vrieze, A., et al